Emerging role of bacteria in oral carcinogenesis: a review with special reference to perio-pathogenic bacteria

References

• Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009; 45: 309–16. [PubMed Abstract].
   Google Scholar
• Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, etal. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer.
   Google Scholar
• Silverman S. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. J Am Dent Assoc. 2001; 132: 7S–11S. [PubMed Abstract].
   Google Scholar
• Alfano MC, Horowitz AM. Professional and community efforts to prevent morbidity and mortality from oral cancer. J Am Dent Assoc. 2001; 132: 24S–9S. [PubMed Abstract].
   Google Scholar
• Wang B, Zhang S, Yue K, Wang XD. The recurrence and survival of oral squamous cell carcinoma: a report of 275 cases. Chin J Cancer. 2013; 32: 614–18. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Vazquez-Mahia I, Seoane J, Varela-Centelles P, Tomas I, Alvarez Garcia A, Lopez Cedrun JL. Predictors for tumor recurrence after primary definitive surgery for oral cancer. J Oral Maxillofac Surg. 2012; 70: 1724–32. [PubMed Abstract].
   Google Scholar
• Petti S. Lifestyle risk factors for oral cancer. Oral Oncol. 2009; 45: 340–50. [PubMed Abstract].
   Google Scholar
• Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, etal. A review of human carcinogens – part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009; 10: 1033–4. [PubMed Abstract].
   Google Scholar
• Syrjänen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol. 2005; 32: 59–66.
   PubMed Web of Science ®Google Scholar
• Gupta B, Johnson NW. Systematic review and meta-analysis of association of smokeless tobacco and of betel quid without tobacco with incidence of oral cancer in South Asia and the Pacific. PLoS One. 2014; 9: e113385. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Petersen PE. Oral cancer prevention and control – the approach of the World Health Organization. Oral Oncol. 2009; 45: 454–60. [PubMed Abstract].
   Google Scholar
• Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulasuriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral oncol. 2004; 40: 304–13. [PubMed Abstract].
   Google Scholar
• Llewellyn C, Johnson NW, Warnakulasuriya K. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case–control study in Southern England. J Oral Pathol Med. 2004; 33: 525–32. [PubMed Abstract].
   Google Scholar
• Bleyer A, editor. Cancer of the oral cavity and pharynx in young females: increasing incidence, role of human papilloma virus, and lack of survival improvement. Semin Oncol. 2009; 36: 451–9.
   Web of Science ®Google Scholar
• Kietthubthew S, Sriplung H, Au WW, Ishida T. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand. Int J Hyg Environ Health. 2006; 209: 21–9. [PubMed Abstract].
   Google Scholar
• Bau D, Tsai M, Huang C, Lee C, Tseng H, Lo Y, etal. Relationship between polymorphisms of nucleotide excision repair genes and oral cancer risk in Taiwan: evidence for modification of smoking habit. Chin J Physiol. 2007; 50: 294. [PubMed Abstract].
   Google Scholar
• Hatagima A, Costa EC, Marques CF, Koifman RJ, Boffetta P, Koifman S. Glutathione S-transferase polymorphisms and oral cancer: a case-control study in Rio de Janeiro, Brazil. Oral Oncol. 2008; 44: 200–7. [PubMed Abstract].
   Google Scholar
• Thornhill MH. The sun, the ozone layer and the skin: the role of ultraviolet light in lip and skin cancer. Dent Update. 1993; 20: 236–40. [PubMed Abstract].
   Google Scholar
• Kumar SKS, Zain RB. Aetiology and risk factors for oral cancer – a brief overview. Annal Dent Univ Malaya. 2004; 11: 41–50.
   Google Scholar
• Meyer MS, Joshipura K, Giovannucci E, Michaud DS. A review of the relationship between tooth loss, periodontal disease, and cancer. Cancer Causes Control. 2008; 19: 895–907. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Hayashi C, Gudino C, Gibson FIII, Genco C. Review: pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol Oral Microbiol. 2010; 25: 305–16. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Chocolatewala N, Chaturvedi P, Desale R. The role of bacteria in oral cancer. Indian J Med Paediatr Oncol. 2010; 31: 126. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Mager D. Bacteria and cancer: cause, coincidence or cure?. A review. J Transl Med. 2006; 4: 14. [PubMed Abstract].
   Google Scholar
• Markowska J, Fischer N, Markowski M, Nalewaj J. The role of Chlamydia trachomatis infection in the development of cervical neoplasia and carcinoma. Med Wieku Rozwoj. 2005; 9: 83–6. [PubMed Abstract].
   Google Scholar
• Nagaraja V, Eslick G. Systematic review with meta-analysis: the relationship between chronic Salmonella typhi carrier status and gall-bladder cancer. Aliment Pharmacol Ther. 2014; 39: 745–50. http://dx.doi.org/10.1111/apt.12655 [PubMed Abstract].
   Google Scholar
• Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, etal. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012; 22: 292–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Toprak NU, Yagci A, Gulluoglu BM, Akin ML, Demirkalem P, Celenk T, etal. A possible role of Bacteroides fragilis enterotoxin in the aetiology of colorectal cancer. Clin Microbiol Infect. 2006; 12: 782–6. [PubMed Abstract].
   Google Scholar
• Meurman JH. Oral microbiota and cancer. J Oral Microbiol. 2010; 2: http://dx.doi.org/10.3402/jom.v2i0.5195.
   Google Scholar
• Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014; 10: e1003933. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009; 31: 1228–39. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Bultman SJ. Emerging roles of the microbiome in cancer. Carcinogenesis. 2014; 35: 249–55. [PubMed Abstract].
   Google Scholar
• Plottel CS, Blaser MJ. Microbiome and malignancy. Cell Host Microbe. 2011; 10: 324–35. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Aagaard K, Petrosino J, Keitel W, Watson M, Katancik J, Garcia N, etal. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. FASEB J. 2013; 27: 1012–22. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486: 207–14. [PubMed CentralFull Text].
   Google Scholar
• Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, etal. Metagenomic analysis of the human distal gut microbiome. Science. 2006; 312: 1355–9. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Turnbaugh PJ, Ley RE, Hamady M, Fraser-Liggett C, Knight R, Gordon JI. The human microbiome project: exploring the microbial part of ourselves in a changing world. Nature. 2007; 449: 804. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, etal. The human oral microbiome. J Bacteriol. 2010; 192: 5002–17. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43: 5721–32. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Do T, Devine D, Marsh PD. Oral biofilms: molecular analysis, challenges, and future prospects in dental diagnostics. Clin Cosmet Investig Dent. 2013; 5: 11–19. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Zarco MF, Vess TJ, Ginsburg GS. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis. 2012; 18: 109–20. [PubMed Abstract].
   Google Scholar
• Chen T, Yu W-H, Izard J, Baranova OV, Lakshmanan A, Dewhirst FE. The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information. Database. 2010; 2010: [PubMed CentralFull Text] baq013.
   Google Scholar
• Sakamoto M, Umeda M, Benno Y. Molecular analysis of human oral microbiota. J Periodontal Res. 2005; 40: 277–85. [PubMed Abstract].
   Google Scholar
• Siqueira JF Jr., Fouad AF, Rocas IN. Pyrosequencing as a tool for better understanding of human microbiomes. J Oral Microbiol. 2012; 4: http://dx.doi.org/10.3402/jom.v4i0.10743.
   Google Scholar
• Parahitiyawa N, Scully C, Leung W, Yam W, Jin L, Samaranayake L. Exploring the oral bacterial flora: current status and future directions. Oral Dis. 2010; 16: 136–45. [PubMed Abstract].
   Google Scholar
• Darveau RP. Periodontitis: a polymicrobial disruption of host homeostasis. Nat Rev Microbiol. 2010; 8: 481–90. [PubMed Abstract].
   Google Scholar
• Takahashi N, Nyvad B. The role of bacteria in the caries process: ecological perspectives. J Dent Res. 2011; 90: 294–303. [PubMed Abstract].
   Google Scholar
• Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. Oral multispecies biofilm development and the key role of cell–cell distance. Nat Rev Microbiol. 2010; 8: 471–80. [PubMed Abstract].
   Google Scholar
• Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998; 25: 134–44. [PubMed Abstract].
   Google Scholar
• Al-hebshi NN, Al-Alimi A, Taiyeb-Ali T, Jaafar N. Quantitative analysis of classical and new putative periodontal pathogens in subgingival biofilm: a case-control study. J Periodontal Res. 2015; 50: 320–9. [PubMed Abstract].
   Google Scholar
• Nagy K, Sonkodi I, Szöke I, Nagy E, Newman H. The microflora associated with human oral carcinomas. Oral Oncol. 1998; 34: 304–8. [PubMed Abstract].
   Google Scholar
• Katz J, Onate MD, Pauley KM, Bhattacharyya I, Cha S. Presence of Porphyromonas gingivalis in gingival squamous cell carcinoma. Int J Oral Sci. 2011; 3: 209–15. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ahn J, Segers S, Hayes RB. Periodontal disease, Porphyromonas gingivalis serum antibody levels and orodigestive cancer mortality. Carcinogenesis. 2012; 33: 1055–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Castellarin M, Warren RL, Freeman JD, Dreolini L, Krzywinski M, Strauss J, etal. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012; 22: 299–306. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Michaud DS, Izard J. Microbiota, oral microbiome, and pancreatic cancer. Cancer J. 2014; 20: 203–6. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Tateda M, Shiga K, Saijo S, Sone M, Hori T, Yokoyama J, etal. Streptococcus anginosus in head and neck squamous cell carcinoma: implication in carcinogenesis. Int J Mol Med. 2000; 6: 699–703. [PubMed Abstract].
   Google Scholar
• Sasaki M, Yamaura C, Ohara-Nemoto Y, Tajika S, Kodama Y, Ohya T, etal. Streptococcus anginosus infection in oral cancer and its infection route. Oral Dis. 2005; 11: 151–6. [PubMed Abstract].
   Google Scholar
• Morita E, Narikiyo M, Yano A, Nishimura E, Igaki H, Sasaki H, etal. Different frequencies of Streptococcus anginosusinfection in oral cancer and esophageal cancer. Cancer Sci. 2003; 94: 492–6. [PubMed Abstract].
   Google Scholar
• Pushalkar S, Ji X, Li Y, Estilo C, Yegnanarayana R, Singh B, etal. Comparison of oral microbiota in tumor and non-tumor tissues of patients with oral squamous cell carcinoma. BMC Microbiol. 2012; 12: 144. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Hooper SJ, Crean S-J, Fardy MJ, Lewis MA, Spratt DA, Wade WG, etal. A molecular analysis of the bacteria present within oral squamous cell carcinoma. J Med Microbiol. 2007; 56: 1651–9. [PubMed Abstract].
   Google Scholar
• Mager D, Haffajee A, Devlin P, Norris C, Posner M, Goodson J. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005; 3: 27. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Hooper SJ, Crean SJ, Lewis MA, Spratt DA, Wade WG, Wilson MJ. Viable bacteria present within oral squamous cell carcinoma tissue. J Clin Microbiol. 2006; 44: 1719–25. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Pushalkar S, Mane SP, Ji X, Li Y, Evans C, Crasta OR, etal. Microbial diversity in saliva of oral squamous cell carcinoma. FEMS Immunol Med Microbiol. 2011; 61: 269–77. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Schmidt BL, Kuczynski J, Bhattacharya A, Huey B, Corby PM, Queiroz EL, etal. Changes in abundance of oral microbiota associated with oral cancer. PLoS One. 2014; 9: e98741. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Al-Hebshi NN, Nasher AT, Idris AM, Chen T. Robust species taxonomy assignment algorithm for 16S rRNA NGS reads: application to oral carcinoma samples. J Oral Microbiol. 2015; 7: 28934,. doi: http://dx.doi.org/10.3402/jom.v7.28934.
   Google Scholar
• Xie H, Onsongo G, Popko J, de Jong EP, Cao J, Carlis JV, etal. Proteomics analysis of cells in whole saliva from oral cancer patients via value-added three-dimensional peptide fractionation and tandem mass spectrometry. Mol Cell Proteomics. 2008; 7: 486–98. [PubMed Abstract].
   Google Scholar
• Nakhjiri SF, Park Y, Yilmaz O, Chung WO, Watanabe K, El-Sabaeny A, etal. Inhibition of epithelial cell apoptosis by Porphyromonas gingivalis. FEMS Microbiol Lett. 2001; 200: 145–9. [PubMed Abstract].
   Google Scholar
• Yilmaz Ö, Jungas T, Verbeke P, Ojcius DM. Activation of the phosphatidylinositol 3-kinase/Akt pathway contributes to survival of primary epithelial cells infected with the periodontal pathogen Porphyromonas gingivalis. Infect Immun. 2004; 72: 3743–51. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Mao S, Park Y, Hasegawa Y, Tribble GD, James CE, Handfield M, etal. Intrinsic apoptotic pathways of gingival epithelial cells modulated by Porphyromonas gingivalis. Cell Microbiol. 2007; 9: 1997–2007. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Yao L, Jermanus C, Barbetta B, Choi C, Verbeke P, Ojcius D, etal. Porphyromonas gingivalis infection sequesters pro-apoptotic Bad through Akt in primary gingival epithelial cells. Mol Oral Microbiol. 2010; 25: 89–101. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Moffatt CE, Lamont RJ. Porphyromonas gingivalis induction of microRNA-203 expression controls suppressor of cytokine signaling 3 in gingival epithelial cells. Infect Immun. 2011; 79: 2632–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Yilmaz Ö, Yao L, Maeda K, Rose TM, Lewis EL, Duman M, etal. ATP scavenging by the intracellular pathogen Porphyromonas gingivalis inhibits P2X7-mediated host-cell apoptosis. Cell Microbiol. 2008; 10: 863–75. [PubMed Abstract].
   Google Scholar
• Groeger S, Domann E, Gonzales JR, Chakraborty T, Meyle J. B7-H1 and B7-DC receptors of oral squamous carcinoma cells are upregulated by Porphyromonas gingivalis. Immunobiology. 2011; 216: 1302–10. [PubMed Abstract].
   Google Scholar
• Binder Gallimidi A, Fischman S, Revach B, Bulvik R, Maliutina A, Rubinstein AM, etal. Periodontal pathogens Porphyromonas gingivalis and Fusobacterium nucleatum promote tumor progression in an oral-specific chemical carcinogenesis model. Oncotarget. 2015; 6: 22613–23. [PubMed Abstract].
   Google Scholar
• Kuboniwa M, Hasegawa Y, Mao S, Shizukuishi S, Amano A, Lamont RJ, etal. P. gingivalis accelerates gingival epithelial cell progression through the cell cycle. Microbes Infect. 2008; 10: 122–8. [PubMed Abstract].
   Google Scholar
• Pan C, Xu X, Tan L, Lin L, Pan Y. The effects of Porphyromonas gingivalis on the cell cycle progression of human gingival epithelial cells. Oral Dis. 2014; 20: 100–8. [PubMed Abstract].
   Google Scholar
• Zhou Y, Sztukowska M, Wang Q, Inaba H, Potempa J, Scott DA, etal. Noncanonical activation of beta-catenin by Porphyromonas gingivalis. Infect Immun. 2015; 83: 3195–203. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Uitto V-J, Baillie D, Wu Q, Gendron R, Grenier D, Putnins EE, etal. Fusobacterium nucleatum increases collagenase 3 production and migration of epithelial cells. Infect Immun. 2005; 73: 1171–9. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Rubinstein MR, Wang X, Liu W, Hao Y, Cai G, Han YW. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe. 2013; 14: 195–206. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Inaba H, Sugita H, Kuboniwa M, Iwai S, Hamada M, Noda T, etal. Porphyromonas gingivalis promotes invasion of oral squamous cell carcinoma through induction of proMMP9 and its activation. Cell Microbiol. 2014; 16: 131–45. [PubMed Abstract].
   Google Scholar
• Inaba H, Amano A, Lamont RJ, Murakami Y. Involvement of protease-activated receptor 4 in over-expression of matrix metalloproteinase 9 induced by Porphyromonas gingivalis. Med Microbiol Immunol. 2015; 204: 605–12. [PubMed Abstract].
   Google Scholar
• Ha NH, Woo BH, Kim da J, Ha ES, Choi JI, Kim SJ, etal. Prolonged and repetitive exposure to Porphyromonas gingivalis increases aggressiveness of oral cancer cells by promoting acquisition of cancer stem cell properties. Tumour Biol. 2015; 36: 9947–60. [PubMed Abstract].
   Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010; 140: 883–99. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA. Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res. 2014; 2014: 149185. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, etal. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe. 2013; 14: 207–15. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• McCoy AN, Araujo-Perez F, Azcarate-Peril A, Yeh JJ, Sandler RS, Keku TO. Fusobacterium is associated with colorectal adenomas. PLoS One. 2013; 8: e53653. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Andrian E, Grenier D, Rouabhia M. In vitro models of tissue penetration and destruction by Porphyromonas gingivalis. Infect Immun. 2004; 72: 4689–98. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Narikiyo M, Tanabe C, Yamada Y, Igaki H, Tachimori Y, Kato H, etal. Frequent and preferential infection of Treponema denticola, Streptococcus mitis, and Streptococcus anginosus in esophageal cancers. Cancer Sci. 2004; 95: 569–74. [PubMed Abstract].
   Google Scholar
• Yumoto H, Nakae H, Yamada M, Fujinaka K, Shinohara C, Ebisu S, etal. Soluble products from Eikenella corrodens stimulate oral epithelial cells to induce inflammatory mediators. Oral Microbiol Immunol. 2001; 16: 296–305. [PubMed Abstract].
   Google Scholar
• Zakhari S. Overview: how is alcohol metabolized by the body?. Alcohol Res Health. 2006; 29: 245–54. [PubMed Abstract].
   Google Scholar
• Seitz H, Gärtner U, Egerer G, Simanowski UA. Ethanol metabolism in the gastrointestinal tract and its possible consequences. Alcohol Alcohol Suppl. 1994; 2: 157–62. [PubMed Abstract].
   Google Scholar
• Seitz HK, Cho CH. Contribution of alcohol and tobacco use in gastrointestinal cancer development. Methods Mol Biol. 2009; 472: 217–41. [PubMed Abstract].
   Google Scholar
• Homann N, Tillonen J, Meurman JH, Rintamäki H, Lindqvist C, Rautio M, etal. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis. 2000; 21: 663–8. [PubMed Abstract].
   Google Scholar
• Väkeväinen S, Mentula S, Nuutinen H, Salmela K, Jousimies-Somer H, Färkkilä M, etal. Ethanol-derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis. Scand J Gastroenterol. 2002; 37: 648–55.
   PubMed Web of Science ®Google Scholar
• Salaspuro MP. Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci. 2003; 40: 183–208. [PubMed Abstract].
   Google Scholar
• Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L, etal. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol. 2007; 43: 181–6. [PubMed Abstract].
   Google Scholar
• Muto M, Hitomi Y, Ohtsu A, Shimada H, Kashiwase Y, Sasaki H, etal. Acetaldehyde production by non-pathogenic Neisseria in human oral microflora: implications for carcinogenesis in upper aerodigestive tract. Int J Cancer. 2000; 88: 342–50. [PubMed Abstract].
   Google Scholar